Genelux Corp. (GNLX)
NASDAQ · Healthcare
Genelux Corp. Revenue 2022–2025
Genelux Corp. annual/quarterly revenue history and growth rate from 2022 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Genelux Corp. revenue for the quarter ending March 31, 2024 was 8000, a 95.29% decrease year-over-year.
- Genelux Corp. annual revenue for 2025 was 8000, a 0.00% increase from 2024.
- Genelux Corp. annual revenue for 2024 was 8000, a 95.29% decrease from 2023.
- Genelux Corp. annual revenue for 2023 was 170000, a 98.46% decrease from 2022.
- Genelux Corp. annual revenue for 2022 was 11.1 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Genelux Corp. (GNLX) — Frequently Asked Questions
Genelux Corp. (GNLX) is a publicly traded US company. In fiscal 2025 it reported revenue of $8,000 and net income of -$32M. Explore GNLX's stock price, financial statements, earnings history, margins and key ratios below.
How much revenue does Genelux Corp. make?
Genelux Corp. reported revenue of $8,000 in fiscal 2025.
Is GNLX profitable?
In fiscal 2025, Genelux Corp. reported net income of -$32M.